590P A Double-Blind, Randomized, Parallel Group Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose HD201, a Trastuzumab Biosimilar Candidate, Versus EU Trastuzumab and US Trastuzumab
Annals of oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要